Barclays PLC Horizon Therapeutics Public LTD CO Put Options Transaction History

Barclays PLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 04, 2023	SELL	$107.32 - $113.5 $17.1 Million - $18.1 Million	-159,800 Reduced 81.95%	35,200 $3.84 Million
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $12.2 Million - $22.2 Million	195,000 New	195,000 $22.2 Million
Q2 2020 Aug 12, 2020	SELL	$30.2 - $56.98 $54,360 - $102,564	-1,800 Reduced 56.25%	1,400 $78,000
Q1 2020 May 13, 2020	SELL	$24.87 - $38.56 $683,925 - $1.06 Million	-27,500 Reduced 89.58%	3,200 $95,000
Q4 2019 Feb 10, 2020	BUY	$25.43 - $36.67 $254,300 - $366,700	10,000 Added 48.31%	30,700 $1.11 Million

Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $331,200 - $402,768	14,400 Added 228.57%	20,700 $564,000
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $143,703 - $179,424	6,300 New	6,300 $152,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.